| 000 | 01738 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516040919.0 | ||
| 264 | 0 | _c20110825 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1533-3450 | ||
| 024 | 7 |
_a10.1681/ASN.2010090956 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Na | |
| 245 | 0 | 0 |
_aSuramin inhibits renal fibrosis in chronic kidney disease. _h[electronic resource] |
| 260 |
_bJournal of the American Society of Nephrology : JASN _cJun 2011 |
||
| 300 |
_a1064-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aFibroblasts _xcytology |
| 650 | 0 | 4 |
_aFibronectins _xmetabolism |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Diseases _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aProteinuria _xprevention & control |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSmad Proteins _xmetabolism |
| 650 | 0 | 4 |
_aSuramin _xpharmacology |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTolbert, Evelyn | |
| 700 | 1 | _aPang, Maoyin | |
| 700 | 1 | _aPonnusamy, Murugavel | |
| 700 | 1 | _aYan, Haidong | |
| 700 | 1 | _aZhuang, Shougang | |
| 773 | 0 |
_tJournal of the American Society of Nephrology : JASN _gvol. 22 _gno. 6 _gp. 1064-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1681/ASN.2010090956 _zAvailable from publisher's website |
| 999 |
_c20877647 _d20877647 |
||